Stephen Denaro - Anteris Technologies Independent Sec

Insider

Stephen Denaro is Independent Sec of Anteris Technologies
Phone61 13 0055 0310
Webhttps://www.anteristech.com

Anteris Technologies Management Efficiency

The company has return on total asset (ROA) of (0.8433) % which means that it has lost $0.8433 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (2.5517) %, meaning that it generated substantial loss on money invested by shareholders. Anteris Technologies' management efficiency ratios could be used to measure how well Anteris Technologies manages its routine affairs as well as how well it operates its assets and liabilities.
Anteris Technologies has accumulated 4.07 M in total debt with debt to equity ratio (D/E) of 0.13, which may suggest the company is not taking enough advantage from borrowing. Anteris Technologies has a current ratio of 4.22, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Anteris Technologies until it has trouble settling it off, either with new capital or with free cash flow. So, Anteris Technologies' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Anteris Technologies sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Anteris to invest in growth at high rates of return. When we think about Anteris Technologies' use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Chad ClouseAurora Spine
N/A
Jason CliftonCellink AB
N/A
Kevin WinterfieldBrain Scientific
N/A
Hassan KotobBrain Scientific
59
Karin DanielssonCellink AB
41
Artur AiraBICO Group AB
56
Hector MartinezCellink AB
38
Itedale RedwanBICO Group AB
N/A
Richard GinnTenon Medical
59
John EsqAinos Inc
57
Karin DanielssonBICO Group AB
41
Mikael EngblomCellink AB
46
Asa HillstenCellink AB
48
Irina NazarovaBrain Scientific
N/A
Vadim SakharovBrain Scientific
49
Erik GatenholmCellink AB
34
Lotta BusCellink AB
53
BonnieJeanne GeretyBrain Scientific
61
Farid AnthonyBrain Scientific
41
Erica BellCellink AB
50
Artur AiraCellink AB
56
Anteris Technologies Ltd operates as a structural heart company. Anteris Technologies Ltd was incorporated in 1999 and is based in Toowong, Australia. Admedus operates under Medical Devices classification in the United States and is traded on OTC Exchange. Anteris Technologies [AMEUF] is a Pink Sheet which is traded between brokers over the counter.

Management Performance

Anteris Technologies Leadership Team

Elected by the shareholders, the Anteris Technologies' board of directors comprises two types of representatives: Anteris Technologies inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Anteris. The board's role is to monitor Anteris Technologies' management team and ensure that shareholders' interests are well served. Anteris Technologies' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Anteris Technologies' outside directors are responsible for providing unbiased perspectives on the board's policies.
AC FAA, Exec
Wayne Paterson, Non-Executive Independent Director
Matthew McDonnell, Chief Officer
David Denis, Chief Officer
Stephen Denaro, Independent Sec
Chris Olig, Bus Director
Danny Zanardo, Commercial International
MPH MD, Chief Board

Anteris Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Anteris Technologies a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.
You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Other Consideration for investing in Anteris Pink Sheet

If you are still planning to invest in Anteris Technologies check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Anteris Technologies' history and understand the potential risks before investing.
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account